Showing results (101-110 of 242) with videos related to

Sort By:
Pageof 25
The Journal of Allergy and Clinical Immunology. Global|June 30, 2025
Refractory marginal zone lymphoma uncovers activated phosphoinositide 3-kinase delta syndrome type 1 (APDS1)Alex Wonnaparhown, Matthew Farley, Holly Miller, et al.
Frontiers in Immunology|July 6, 2016
Genetic Diagnosis Using Whole Exome Sequencing in Common Variable ImmunodeficiencyPatrick Maffucci, Charles A Filion, Bertrand Boisson, et al.
The Journal of Allergy and Clinical Immunology. in Practice|October 4, 2016
Hemoptysis in a Patient with Elevated Immunoglobulin EYael Gernez, Angela Tsuang, Tukisa D Smith, et al.
Nucleic Acids Research|January 14, 2021
LIG1 syndrome mutations remodel a cooperative network of ligand binding interactions to compromise ligation efficiencyThomas J Jurkiw, Percy P Tumbale, Matthew J Schellenberg, et al.
European Journal of Immunology|December 11, 2012
Naturally occurring mutation affecting the MyD88-binding site of TNFRSF13B impairs triggering of class switch recombinationMaria B Almejun, Montserrat Cols, Marta Zelazko, et al.
The Journal of Experimental Medicine|June 15, 2007
CD40 ligand and MHC class II expression are essential for human peripheral B cell toleranceMaxime Hervé, Isabelle Isnardi, Yen-shing Ng, et al.
The Journal of Allergy and Clinical Immunology|September 8, 2020
Targeting FcRn for immunomodulation: Benefits, risks, and practical considerationsHans-Hartmut Peter, Hans D Ochs, Charlotte Cunningham-Rundles, et al.
The Journal of Allergy and Clinical Immunology|October 20, 2015
CD19 controls Toll-like receptor 9 responses in human B cellsHenner Morbach, Jean-Nicolas Schickel, Charlotte Cunningham-Rundles, et al.
The Journal of Allergy and Clinical Immunology|November 7, 2007
Transmembrane activator and calcium-modulating cyclophilin ligand interactor mutations in common variable immunodeficiency: clinical and immunologic outcomes in heterozygotesLi Zhang, Lin Radigan, Ulrich Salzer, et al.
Clinical Immunology (Orlando, Fla.)|April 15, 2024
ICOS agonist vopratelimab modulates follicular helper T cells and improves B cell function in common variable immunodeficiencyAli Sepahi, Hsi-En Ho, Prapti Vyas, et al.
Pageof 25